Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study-Reference-Cited by-同舟云学术

Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study

Published:2022-03-04 Issue:3 Volume:22 Page:387-394
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Lu Yanmei¹,Linpeng Siyuan¹,Ding Siyi¹,Li Shihong¹,Shi Liangcheng¹,Zuo Xinwei¹,He Jun¹,Liu Yalan²

Affiliation:

1. Department of Genetic Eugenics, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha Hunan, China

2. Department of Otolaryngology Heard and Neck Surgery, Xiangya Hospital, Central South University, Changsha Hunan, China

Funder

Changsha Maternity and Child Health Hospital

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2022.2049245

Reference24 articles.

1. The Clinical Utility of Non-invasive Prenatal Testing for Pregnant Women With Different Diagnostic Indications

2. Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study

3. Prenatal Screening for Aneuploidy

4. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China

5. Presence of fetal DNA in maternal plasma and serum

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance analysis of non-invasive prenatal testing for trisomy 13, 18, and 21: A large-scale retrospective study (2018–2021);Heliyon;2024-07

2. Limited ability of increased sequencing depth in detecting cases missed by noninvasive prenatal testing: a comparative analysis of 3 clinical cases;Scientific Reports;2024-01-27

3. Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results;American Journal of Obstetrics and Gynecology;2023-09

4. Analysis of retest reliability for pregnant women undergoing cfDNA testing with a no-call result;Molecular Biology Reports;2023-08-03

5. Cell-free DNA Screening for Aneuploidy;Clinical Obstetrics & Gynecology;2023-07-17